Management of Type 1 Diabetes: ICMR releases guidelines
More than one million children and adolescents in the world have type 1 diabetes, and recent estimates from the International Diabetes Federation suggest that India has the highest number of cases of type 1 diabetes in the world.
New Delhi: The apex research body, the Indian Council of Medical Research (ICMR) has issued guidelines for the management of type 1 diabetes in India.
This is the first time that the research body has released guidelines for type 1 diabetes. Earlier, guidelines were released for type 2 diabetes.
Also Read:ICMR releases guidelines for drone use in healthcare
Balram Bhargava, Department of Health Research Secretary and ICMR Director General, released the guidelines for the management of type 1 diabetes.
The ICMR guidelines come at a time when the SARS-CoV-2 pandemic has disproportionately affected people suffering from diabetes, exposing them to a high risk for severe illness and mortality.
India is home to the world's second largest adult diabetes population and every sixth person with diabetes in the world is an Indian.
More than one million children and adolescents in the world have type 1 diabetes, and recent estimates from the International Diabetes Federation suggest that India has the highest number of cases of type 1 diabetes in the world, said ICMR in the guidelines.
As per the ICMR report, the past three decades witnessed a 150 per cent increase in the number of people with diabetes in the country.
The growing prevalence of pre-diabetes indicates a further increase in diabetes in the near future.
Diabetes in India has traversed from high to the middle income and underprivileged sections of society, said ICMR in the guidelines.
Globally, diabetes was responsible for more than four million deaths in 2019.
It was the leading cause of end-stage kidney disease, adult-onset blindness and cardiovascular diseases.
There was considerable heterogeneity in the prevalence of complications and deaths associated with diabetes across countries.
The ICMR in the guidelines has underlined that progressive lowering of the age at which type 2 diabetes is presenting, with an inflection in disease prevalence becoming apparent in the age group of 25-34 years in both urban and rural areas is a matter of immense concern.
The ICMR type 1 diabetes guidelines is a comprehensive document providing advice on care of diabetes in children, adolescents and adults.
While speaking to ANI, Dr Nikhil Tandon, Head of the department of endocrinology, AIIMS Delhi explained the major highlights of the guidelines about the Type 1 Diabetes affecting children and adolescents, management of the disease and complications.
He said, "Type-1 diabetes, predominantly manifests early in life – affecting children and adolescents, thereby resulting in a prolonged period of life spent with the disease. It is a potentially life-threatening condition, and if left undiagnosed and/or inadequately treated can result in acute metabolic complications which may lead to loss of life."
"The guidelines provide a practical approach to the management of this condition and its complications. The contributors include specialists in the field of endocrinology, diabetology, paediatrics, nephrology, ophthalmology, cardiology, neurology, nutrition sciences," he said.
All chapters in these guidelines have been provided with formation to reflect advances in scientific knowledge and clinical care that have occurred in the recent past.
Also Read:J&K: 2 Govt hospitals selected for ICMR's palliative care project
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.